» Articles » PMID: 20060342

Parathyroid Hormone-related Peptide (PTHrP), Parathyroid Hormone/parathyroid Hormone-related Peptide Receptor 1 (PTHR1), and MSX1 Protein Are Expressed in Central and Peripheral Giant Cell Granulomas of the Jaws

Overview
Publisher Elsevier
Date 2010 Jan 12
PMID 20060342
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Parathyroid hormone-related peptide (PTHrP) binds to the parathyroid hormone receptor type 1 (PTHR1), which results in the activation of pathways in osteoblasts that promote osteoclastogenesis through the RANK/RANKL system. RANK/RANKL expression has been shown in central giant cell granuloma of the jaws but PTHrP/PTHR1 has not. MSX1 protein is a classical transcription regulator which promotes cell proliferation and inhibits cell differentiation by inhibiting master genes in tissues such as bone and muscle. It has been implicated in the pathogenesis of cherubism, and its expression has been reported in a single central giant cell granuloma (CGCG) case. We aimed, therefore, to study the expression of those proteins by the different cellular populations of central and peripheral giant cell granulomas (PGCGs) of the jaws.

Study Design: Twenty cases of CGCG and 20 cases of PGCG of the jaws were retrospectively examined by immunohistochemistry for the percentage of positively staining cells to antibodies for PTHrP, PTHR1, and MSX1, using a semiquantitative method.

Results: In both CGCG and PGCG of the jaws, PTHrP and PTHR1 were abundantly expressed by type I multinucleated giant cells (MGC) and mononucleated stromal cells (MSC) with vesicular nuclei, whereas type II MGC and MSC with pyknotic nuclei expressed those proteins to a lesser extent. In both CGCG and PGCG of the jaws, MSX1 was abundantly expressed by type I MGC and MSC but type II MGC did not express it. A statistically significant difference (P < .05) was observed between CGCG and PGCG in the expression of PTHrP in type II MGC and MSC with pyknotic nuclei and in the expression of PTHR1 in type II MGC.

Conclusions: We suggest that in CGCG and PGCG of the jaws, PTHrP-positive immature osteoblasts activate PTHR1-positive mature osteoblasts to produce RANKL which interacts with RANK on the PTHrP/PTHR1-positive osteoclast-precursor cells found in abundance in the stroma of giant cell lesions and induces osteoclastogenesis through the classic pathway. Cells of the jawbones, the periodontal ligament, or the dental follicle, originating from the neural crest, may be involved in the pathogenesis of giant cell lesions of the jaws. Further study is required for these suggestions to be proved.

Citing Articles

Thoughts on the Etiology of Cherubism.

Hyckel P, Liehr T J Clin Med. 2024; 13(7).

PMID: 38610846 PMC: 11012468. DOI: 10.3390/jcm13072082.


Unravelling the role of immunohistochemistry in giant cell lesions of jaws: A systematic review.

Gupta S, Sharma D, Hooda A, Sharma V, Kamboj M J Oral Maxillofac Pathol. 2023; 27(1):181-194.

PMID: 37234327 PMC: 10207225. DOI: 10.4103/jomfp.jomfp_18_22.


Peripheral Giant Cell Granuloma in a Child Associated with Ectopic Eruption and Traumatic Habit with Control of Four Years.

Volpato L, Leite C, Anhesini B, Aguilera J, Borges A Case Rep Dent. 2016; 2016:6725913.

PMID: 27999690 PMC: 5143708. DOI: 10.1155/2016/6725913.


A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique.

Zargaran M, Moghimbeigi A, Afsharmoghadam N, Nasr Isfahani M, Hashemi A J Dent (Shiraz). 2016; 17(2):98-104.

PMID: 27284554 PMC: 4885679.


MiR-125b inhibits stromal cell proliferation in giant cell tumor of bone by targeting parathyroid hormone 1 receptor.

Wu P, Liang J, Yu F, Zhou Z, Tang J, Li K Iran J Basic Med Sci. 2015; 18(7):705-9.

PMID: 26351562 PMC: 4556765.